Stephen P. Ewald, General Counsel and Corporate Secretary of Medpace Holdings, Inc., filed a Form 4 on November 2, 2026, disclosing the sale of 1,245 shares of common stock on October 29, 2026.

Key Highlights

  • Reporting person: Stephen P. Ewald, General Counsel and Corporate Secretary of Medpace Holdings, Inc. (NASDAQ:MEDP)
  • Transaction: 1,245 shares of common stock disposed of (transaction code S) on October 29, 2026
  • Sale price: $690 per share
  • Remaining ownership: 19,098 shares of common stock held directly following the transaction
  • Transaction basis: The sale was effected pursuant to a limit order placed by the reporting person during an open window period

Ewald's October 2026 Open-Window Sale of Medpace Common Stock

According to the filing, Stephen P. Ewald, who serves as General Counsel and Corporate Secretary of Medpace Holdings, Inc., disposed of 1,245 shares of Medpace common stock on October 29, 2026, at a price of $690 per share. The transaction is coded "S," indicating a sale, and the shares were held directly by the reporting person.

The filing notes in its explanation of responses that "the transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period." No Rule 10b5-1(c) plan box is checked on the form. Following the reported transaction, Ewald directly holds 19,098 shares of Medpace common stock, according to the filing. No derivative securities transactions were reported in Table II.

What Was Disclosed

The Form 4 filed November 2, 2026 discloses that Stephen P. Ewald, General Counsel and Corporate Secretary of Medpace Holdings, Inc. (NASDAQ:MEDP), sold 1,245 shares of common stock at $690 per share on October 29, 2026, leaving him with 19,098 directly held shares.